Mylotarg was approved to treat patients ages 60 years and older with recurrent AML who were not considered candidates for other chemotherapy.
麦罗塔已被批准用于治疗60岁及以上伴有复发性aml且不考虑接受其他化疗的患者。
A stem cell transplant (sometimes called a bone marrow transplant) is a treatment used for some patients who have AML.
造血干细胞移植(有时也称为骨髓移植)，是治疗急性髓细胞白血病的一种手段。
Allogeneic stem cell transplants may be used in children who are not doing well or whose AML returns (called a relapse) after high-dose chemotherapy.
若急粒患儿在接受了大剂量化疗后病情未见好转或病情复发，可采用异基因造血干细胞移植进行治疗。
应用推荐